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OBJECTIVE — To assess the relationship between albuminuria, including elevation within
the normal range, and decline in glomerular ﬁltration rate (GFR) in diabetic patients.
RESEARCH DESIGN AND METHODS — A total of 5,449 Japanese diabetic patients
were categorized according to sex and urinary albumin-to-creatinine ratio (ACR; 5, 5–9,
10–29, 30–99, 100–299, 300–999, 1,000–2,999, and 3,000 mg/g) and followed for at least
5 years. The rate of change in estimated GFR (eGFR) adjusted for age and baseline eGFR was
compared among ACR categories.
RESULTS — A higher baseline ACR predicted a faster decline in eGFR for both sexes. Even
within the normal range (30 mg/g), ACR 10 mg/g in women and 5 mg/g in men was
associated with a signiﬁcantly greater rate of decline in eGFR relative to subjects with ACR 5
mg/g.
CONCLUSIONS — Elevated ACR, even within the normal range, is associated with a faster
decline in eGFR in diabetic patients.
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A
lbuminuria and proteinuria are as-
sociated with subsequent progres-
sion of diabetic kidney disease (1–
3). Recent studies suggest that elevated
urinary albumin excretion, even within
thenormalrange,isalsoassociatedwitha
greater risk of cardiovascular disease (4–
6). Because normal urinary albumin ex-
cretionisdeﬁnedusinganarbitrarycutoff
value (albumin-to-creatinine ratio [ACR]
30 mg/g [7]), we sought to determine
whether diabetic patients with high-
normal–range ACR have a faster decline
in glomerular ﬁltration rate (GFR).
RESEARCH DESIGN AND
METHODS— The study was con-
ducted in accordance with the Declara-
tion of Helsinki. Subjects were recruited
from Japanese patients with type 1 and
type 2 diabetes, 18 years or older, who
visited the Diabetes Center, Tokyo Wom-
en’sMedicalUniversityHospital,between
February 1995 and May 2003. Subjects
were eligible for inclusion if they had at
least two determinations of urinary ACR
and at least one measurement of serum
creatinine within the 12-month baseline
period.Patientswereexcludediftheyhad
been treated with renal replacement ther-
apy at baseline or started renal replace-
ment therapy within 5 years of the
baseline assessment, or if they had 5
yearsoffollow-upsincetheﬁrstmeasure-
ment of serum creatinine. Patients were
also excluded if their baseline value of es-
timated GFR (eGFR) was 200 ml/min
per 1.73 m
2 (considered physiologically
implausible [8]).
Geometric mean ACR was deter-
mined from two consecutive ﬁrst-
morning urine samples and used to
categorize subjects as follows: nor-
moalbuminuria (ACR 30 mg/g), mi-
croalbuminuria(ACR30–299mg/g),and
macroalbuminuria(ACR300mg/g)(7).
Subjects were further divided by sex into
eight ACR subcategories: 5, 5–9, 10–
29, 30–99, 100–299, 300–999, 1,000–
2,999, and 3,000 mg/g.
The primary outcome was the rate
of change in eGFR during the follow-up
period. GFR was estimated using the fol-
lowing modiﬁed three-variable equation
for Japanese, as recently proposed by
the Japanese Society for Nephrology:
GFR  194  serum creatinine
1.094 
age
0.2870.739(iffemale)(9).Therate
of change in eGFR per year was deter-
mined using a simple regression analysis,
applied to all estimates of GFR obtained
duringthefollow-upperiod(10).Patients
were followed at least 5 years.
The rate of change in eGFR, ex-
pressed as least-square mean  SE, was
compared among ACR categories and
subcategoriesusingANCOVA(SAS/STAT
version 9.13; Cary, NC). A P value 0.05
was considered signiﬁcant.
RESULTS— A total of 5,449 diabetic
patients had sufﬁcient baseline and fol-
low-up data to qualify for inclusion. The
study population (15% type 1 diabetes)
included 2,359 women and 3,090 men
with a mean (SD) age of 53  14 years
(range 18–87). Mean baseline serum cre-
atininelevelsandeGFRwere0.650.22
mg/dl (0.24–4.66) and 95.7  25.8 ml/
min per 1.73 m
2 (11.9–199.9), respec-
tively. The mean follow-up period was
9.2  2.4 years (5.0–13.1).
Among ACR categories and subcate-
gories, higher levels of ACR were associ-
atedwithafasterdeclineineGFRforboth
women and men (Fig. 1 and the Supple-
mental Table, available in the online-only
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within the normal range (30 mg/g),
ACR 10 mg/g in women and 5 mg/g
in men was associated with a signiﬁcantly
greater rate of decline in eGFR relative to
subjects with ACR 5 mg/g. When ana-
lyzed for all eight ACR subcategories,
women had a faster decline in eGFR than
men (P  0.001). For both sexes, the
rate of decline in eGFR was maximal for
the ACR 1,000–2,999 mg/g subcategory
and slightly lower for the highest ACR
subcategory.
CONCLUSIONS — In this large hos-
pital-based observational cohort study in
Japanese diabetic patients, we observed a
greater rate of decline in eGFR in subjects
withhigherlevelsofACR,evenwithinthe
arbitrarily deﬁned normal range. These
data support previous studies showing a
close relationship between albuminuria
and rapid progression of diabetic kidney
disease (1–3) and suggest such a relation-
ship may extend to conventionally de-
ﬁned normoalbuminuria. Recent studies
indicate the risk of cardiovascular disease
and death increases for high-normal–
range albuminuria (4–6), raising the
issue whether a new deﬁnition of nor-
moalbuminuria should be advocated
(4–6,11).
The relationship between baseline
ACR and rate of decline in eGFR was ap-
parent for both sexes but with subtle dif-
ferences. Although the rate of decline in
eGFR tended to be greater in normoalbu-
minuric women, a stronger relationship
wasobservedbetweenhigherACR(inthe
normal range) and the rate of decline in
eGFR in men. Our study suggests that the
threshold of ACR identifying diabetic pa-
tients with a higher risk of progression of
diabetic kidney disease may be lower in
men than women, consistent with previ-
ousinvestigationsadvocatingalowercut-
off value for albuminuria in men (12,13).
The relatively fast rate of decline in eGFR
in patients in this study compared with
thatreportedinotherstudies(14)maybe
explained by differences in the duration
of follow-up, higher baseline eGFR, pres-
ence of diabetes, racial factors, or other
differences in this population.
This study addresses the association
between baseline values of ACR and the
change in GFR over time, without assess-
ingintra-individualchangeinACR.Thus,
the study does not differentiate between
patients in the normal range who had
staticorincreasingvaluesofACR.Further
studies are needed to determine whether
increasingACRvaluesovertimemaypre-
dict a faster decline in GFR. Other limita-
tions of this study include its ethnically
and socially homogenous population and
possible underestimation of the decline
in eGFR in patients with higher levels
of baseline ACR due to exclusion of
patients starting renal replacement
therapy during the 5-year follow-up.
Nevertheless, the study’s large sample
size, long duration of follow-up, and
consistent use of ﬁrst-morning speci-
mens (15) strengthen its potential rele-
vance to clinical practice.
Figure1—ComparisonoftherateofchangeineGFR,adjustedforageandbaselineeGFR,among
traditionalcategories(A)andsubcategoriesoftheurinaryACR(B),basedonthegeometricmean
of two consecutive measurements. White and black bars represent least-square mean (SE) for
womenandmen,respectively.*P0.05vs.normoalbuminuria(A)andACR5mg/gcreatinine
(B), by ANCOVA.
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even within the normal range, are associ-
ated with a faster decline in eGFR in dia-
betic patients. Further studies are needed
to determine whether lower and/or sex-
speciﬁc thresholds for ACR, or sensitive
measurements of incremental rise in ACR
over time, may be useful to indentify dia-
betic patients at a higher risk for progres-
sion of diabetic kidney disease.
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